相似文献
1
Role of the microenvironment in myeloid malignancies.
Cell Mol Life Sci. 2018 Apr;75(8):1377-1391. doi: 10.1007/s00018-017-2725-4. Epub 2017 Dec 8.
2
Myeloid malignancies and the microenvironment.
Blood. 2017 Feb 16;129(7):811-822. doi: 10.1182/blood-2016-09-670224. Epub 2016 Nov 15.
3
Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking Up an Intimate Relationship.
Adv Cancer Res. 2015;127:227-52. doi: 10.1016/bs.acr.2015.04.007. Epub 2015 May 19.
4
Bone, microenvironment and hematopoiesis.
Curr Opin Hematol. 2012 Jul;19(4):250-5. doi: 10.1097/MOH.0b013e328353c714.
5
The Bone Marrow Microenvironment in Health and Myeloid Malignancy.
Cold Spring Harb Perspect Med. 2018 Jul 2;8(7):a031328. doi: 10.1101/cshperspect.a031328.
6
Role of secreted factors in the regulation of hematopoietic stem cells by the bone marrow microenvironment.
Front Biosci (Landmark Ed). 2012 Jan 1;17(3):876-91. doi: 10.2741/3962.
7
The hematopoietic stem-cell niche in health and leukemia.
Cell Mol Life Sci. 2017 Feb;74(4):579-590. doi: 10.1007/s00018-016-2306-y. Epub 2016 Jul 19.
8
The HSC niche concept has turned 31. Has our knowledge matured?
Ann N Y Acad Sci. 2010 Mar;1192:12-8. doi: 10.1111/j.1749-6632.2009.05223.x.
9
The hematopoietic stem cell niche.
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):30-9. doi: 10.2741/3913.
10
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Oncotarget. 2016 Jul 5;7(27):41217-41232. doi: 10.18632/oncotarget.9251.
引用本文的文献
1
Blood Serum from Patients with Acute Leukemia Inhibits the Growth of Bone Marrow Multipotent Mesenchymal Stromal Cells.
Biomedicines. 2025 May 21;13(5):1265. doi: 10.3390/biomedicines13051265.
2
Recent advances in osteonecrosis of the femoral head: a focus on mesenchymal stem cells and adipocytes.
J Transl Med. 2025 May 27;23(1):592. doi: 10.1186/s12967-025-06564-6.
3
Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets.
Med Oncol. 2024 Dec 7;42(1):23. doi: 10.1007/s12032-024-02575-3.
4
From Marrow to Bone and Fat: Exploring the Multifaceted Roles of Leptin Receptor Positive Bone Marrow Mesenchymal Stromal Cells.
Cells. 2024 May 24;13(11):910. doi: 10.3390/cells13110910.
5
Y-box binding protein 1 in small extracellular vesicles reduces mesenchymal stem cell differentiation to osteoblasts-implications for acute myeloid leukaemia.
J Extracell Vesicles. 2024 Mar;13(3):e12417. doi: 10.1002/jev2.12417.
6
Mesenchymal stromal cells in myeloid malignancies: Immunotherapeutic opportunities.
Heliyon. 2024 Jan 22;10(3):e25081. doi: 10.1016/j.heliyon.2024.e25081. eCollection 2024 Feb 15.
7
Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy.
Cell Death Dis. 2023 Dec 5;14(12):796. doi: 10.1038/s41419-023-06325-7.
8
Bone Marrow Microenvironment Involvement in t-MN: Focus on Mesenchymal Stem Cells.
Mediterr J Hematol Infect Dis. 2023 Sep 1;15(1):e2023055. doi: 10.4084/MJHID.2023.055. eCollection 2023.
9
Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells.
Int J Mol Sci. 2023 May 18;24(10):8953. doi: 10.3390/ijms24108953.
10
Extracellular Vesicles and MicroRNA in Myelodysplastic Syndromes.
Cells. 2023 Feb 19;12(4):658. doi: 10.3390/cells12040658.
本文引用的文献
1
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche.
Nat Cell Biol. 2017 Nov;19(11):1336-1347. doi: 10.1038/ncb3625. Epub 2017 Oct 16.
2
CXCL12/CXCR4 pathway is activated by oncogenic JAK2 in a PI3K-dependent manner.
Oncotarget. 2016 Jul 22;8(33):54082-54095. doi: 10.18632/oncotarget.10789. eCollection 2017 Aug 15.
3
Origins of myelodysplastic syndromes after aplastic anemia.
Blood. 2017 Oct 26;130(17):1953-1957. doi: 10.1182/blood-2017-02-767731. Epub 2017 Sep 11.
4
Human Primary Bone Marrow Mesenchymal Stromal Cells and Their in vitro Progenies Display Distinct Transcriptional Profile Signatures.
Sci Rep. 2017 Sep 4;7(1):10338. doi: 10.1038/s41598-017-09449-x.
5
Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia.
Cancer Cell. 2017 Sep 11;32(3):324-341.e6. doi: 10.1016/j.ccell.2017.08.001. Epub 2017 Sep 1.
6
Methylome Analysis of Human Bone Marrow MSCs Reveals Extensive Age- and Culture-Induced Changes at Distal Regulatory Elements.
Stem Cell Reports. 2017 Sep 12;9(3):999-1015. doi: 10.1016/j.stemcr.2017.07.018. Epub 2017 Aug 24.
7
CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia.
Stem Cell Res Ther. 2017 Aug 1;8(1):178. doi: 10.1186/s13287-017-0620-4.
8
Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation.
Cancer Res. 2017 Sep 15;77(18):4846-4857. doi: 10.1158/0008-5472.CAN-17-0282. Epub 2017 Jul 6.
9
AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth.
JCI Insight. 2017 Jul 6;2(13). doi: 10.1172/jci.insight.90036.
10
Preclinical modeling of myelodysplastic syndromes.
Leukemia. 2017 Dec;31(12):2702-2708. doi: 10.1038/leu.2017.172. Epub 2017 Jun 2.
Zotero 插件
